M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1

References

• Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85–94. doi:10.1016/S0140-6736(16)00645-0
   PubMed Web of Science ®Google Scholar
• Schrenk S, Boscolo E. A transcription factor is the target of propranolol treatment in infantile hemangioma. J Clin Invest. 2022;132(3):e156863. doi:10.1172/JCI156863
   PubMed Web of Science ®Google Scholar
• Chen J, Chen Q, Qiu Y, et al. CD146+ mural cells from infantile hemangioma display proangiogenic ability and adipogenesis potential in vitro and in xenograft models. Front Oncol. 2023;13:1063673. doi:10.3389/fonc.2023.1063673
   PubMed Web of Science ®Google Scholar
• Fu R, Zou Y, Wu Z, et al. Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population. Sci Rep. 2023;13(1):5956. doi:10.1038/s41598-023-33105-2
   PubMed Web of Science ®Google Scholar
• Kong M, Li Y, Wang K, Zhang S, Ji Y. Infantile hemangioma models: is the needle in a haystack? J Transl Med. 2023;21(1):308. doi:10.1186/s12967-023-04144-0
   PubMed Web of Science ®Google Scholar
• Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–746. doi:10.1056/NEJMoa1404710
   PubMed Web of Science ®Google Scholar
• Gong X, Li Y, Yang K, Chen S, Ji Y. Infantile hepatic hemangiomas: looking backwards and forwards. Precis Clin Med. 2022;5(1):bac006. doi:10.1093/pcmedi/pbac006
   Google Scholar
• Komal S, Han SN, Cui LG, et al. Epigenetic regulation of macrophage polarization in cardiovascular diseases. Pharmaceuticals. 2023;16(2):141. doi:10.3390/ph16020141
   Web of Science ®Google Scholar
• Wang H, Ye X, Spanos M, et al. Exosomal non-coding RNA mediates macrophage polarization: roles in cardiovascular diseases. Biology. 2023;12(5):745. doi:10.3390/biology12050745
   PubMedGoogle Scholar
• Zhang W, Chen G, Wang FQ, et al. Macrophages contribute to the progression of infantile hemangioma by regulating the proliferation and differentiation of hemangioma stem cells. J Invest Dermatol. 2015;135(12):3163–3172. doi:10.1038/jid.2015.321
   PubMed Web of Science ®Google Scholar
• Wang FQ, Chen G, Zhu JY, et al. M2-polarised macrophages in infantile haemangiomas: correlation with promoted angiogenesis. J Clin Pathol. 2013;66(12):1058–1064. doi:10.1136/jclinpath-2012-201286
   PubMed Web of Science ®Google Scholar
• Liao XM, Guan Z, Yang ZJ, et al. Comprehensive analysis of M2 macrophage-derived exosomes facilitating osteogenic differentiation of human periodontal ligament stem cells. BMC Oral Health. 2022;22(1):647. doi:10.1186/s12903-022-02682-5
   PubMed Web of Science ®Google Scholar
• Wang QZ, Zhao ZL, Liu C, Zheng JW. Exosome-derived miR-196b-5p facilitates intercellular interaction in infantile hemangioma via down-regulating CDKN1B. Ann Transl Med. 2021;9(5):394. doi:10.21037/atm-20-6456
   PubMed Web of Science ®Google Scholar
• Liu C, Zhao Z, Guo S, Zhang L, Fan X, Zheng J. Exosomal miR-27a-3p derived from tumor-associated macrophage suppresses propranolol sensitivity in infantile hemangioma. Cell Immunol. 2021;370:104442. doi:10.1016/j.cellimm.2021.104442
   PubMed Web of Science ®Google Scholar
• Hong Y, Zhang Y, Zhao H, Chen H, Yu QQ, Cui H. The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma. Front Cell Dev Biol. 2022;10:1051306. doi:10.3389/fcell.2022.1051306
   PubMed Web of Science ®Google Scholar
• Sun CC, Li L, Jiang ZC, Liu ZC, Wang L, Wang HJ. The functional role of LncRNA UCA1 in pancreatic cancer: a mini-review. J Cancer. 2023;14(2):275–280. doi:10.7150/jca.79171
   PubMed Web of Science ®Google Scholar
• Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA. Long noncoding RNAs in cancer metastasis. Nat Rev Cancer. 2021;21(7):446–460. doi:10.1038/s41568-021-00353-1
   PubMed Web of Science ®Google Scholar
• Zhong C, Xie Z, Zeng LH, Yuan C, Duan S. MIR4435-2HG is a potential pan-cancer biomarker for diagnosis and prognosis. Front Immunol. 2022;13:855078. doi:10.3389/fimmu.2022.855078
   PubMedGoogle Scholar
• Li S, Hu X, Yu S, et al. Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG / miR -506-3p/ TGFB1 axis. Cancer Sci. 2023;114(2):504–520. doi:10.1111/cas.15605
   PubMed Web of Science ®Google Scholar
• Ke J, Wang Q, Zhang W, Ni S, Mei H. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer. Am J Transl Res. 2022;14(8):5441–5454.
   PubMed Web of Science ®Google Scholar
• Yang T, Li Y, Wang G, et al. lncRNA MIR4435-2HG accelerates the development of bladder cancer through enhancing IQGAP3 and CDCA5 Expression. Biomed Res Int. 2022;2022:3858249. doi:10.1155/2022/3858249
   PubMed Web of Science ®Google Scholar
• Zhang M, Yu X, Zhang Q, Sun Z, He Y, Guo W. MIR4435-2HG: a newly proposed lncRNA in human cancer. Biomed Pharmacother. 2022;150:112971. doi:10.1016/j.biopha.2022.112971
   PubMed Web of Science ®Google Scholar
• Wang L, Zou Y, Huang Z, et al. KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells. Cancer Sci. 2023;114(4):1569–1581. doi:10.1111/cas.15708
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhou H, Zhou Y, Song C. M2 macrophage-derived exosomes inhibit apoptosis of HUVEC cell through regulating miR-221-3p expression. Biomed Res Int. 2022;2022:1609244. doi:10.1155/2022/1609244
   PubMed Web of Science ®Google Scholar
• Wei K, Ma Z, Yang F, et al. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942. Cancer Lett. 2022;526:205–216. doi:10.1016/j.canlet.2021.10.045
   PubMed Web of Science ®Google Scholar
• Yang Y, Guo Z, Chen W, et al. M2 macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Mol Ther. 2021;29(3):1226–1238. doi:10.1016/j.ymthe.2020.11.024
   PubMed Web of Science ®Google Scholar
• Wu K, Muratore CS, So EY, et al. M1 macrophage-induced endothelial-to-mesenchymal transition promotes infantile hemangioma regression. Am J Pathol. 2017;187(9):2102–2111. doi:10.1016/j.ajpath.2017.05.014
   PubMed Web of Science ®Google Scholar
• Zhou L, Jia X, Yang X. LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis. Hum Genomics. 2021;15(1):50. doi:10.1186/s40246-021-00349-w
   PubMed Web of Science ®Google Scholar
• Li MM, Dong CX, Sun B, et al. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway. Life Sci. 2019;239:116946. doi:10.1016/j.lfs.2019.116946
   PubMed Web of Science ®Google Scholar
• Zhao F, Liu Y, Tan F, et al. MIR4435-2HG: a tumor-associated long non-coding RNA. Curr Pharm Des. 2022;28(25):2043–2051. doi:10.2174/1381612828666220607100228
   PubMed Web of Science ®Google Scholar
• Ghasemian M, Rajabibazl M, Sahebi U, et al. Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders. Cancer Cell Int. 2022;22(1):215. doi:10.1186/s12935-022-02633-8
   PubMed Web of Science ®Google Scholar
• Han P, Cao P, Yue J, et al. Knockdown of hnRNPA1 promotes NSCLC metastasis and EMT by regulating alternative splicing of LAS1L exon 9. Front Oncol. 2022;12:837248. doi:10.3389/fonc.2022.837248
   PubMed Web of Science ®Google Scholar
• Roy R, Huang Y, Seckl MJ, Pardo OE. Emerging roles of hnRNPA1 in modulating malignant transformation. Wiley Interdiscip Rev RNA. 2017;8(6). doi:10.1002/wrna.1431
   PubMed Web of Science ®Google Scholar
• Lan Z, Yao X, Sun K, Li A, Liu S, Wang X. The interaction between lncRNA SNHG6 and hnRNPA1 contributes to the growth of colorectal cancer by enhancing aerobic glycolysis through the regulation of alternative splicing of PKM. Front Oncol. 2020;10:363. doi:10.3389/fonc.2020.00363
   PubMed Web of Science ®Google Scholar
• Wen Z, Lian L, Ding H, et al. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. RNA Biol. 2020;17(3):381–394. doi:10.1080/15476286.2019.1708547
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431–436. doi:10.1038/nature04870
   PubMed Web of Science ®Google Scholar
• Wang R, Ma Y, Zhan S, et al. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Cell Death Dis. 2020;11(1):55. doi:10.1038/s41419-020-2252-3
   PubMed Web of Science ®Google Scholar
• Greenberger S, Adini I, Boscolo E, Mulliken JB, Bischoff J. Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis. 2010;13(4):327–335. doi:10.1007/s10456-010-9189-6
   PubMed Web of Science ®Google Scholar
• Xu W, Li S, Yu F, et al. Role of thrombospondin-1 and nuclear factor-κB signaling pathways in antiangiogenesis of infantile hemangioma. Plast Reconstr Surg. 2018;142(3):310e–321e. doi:10.1097/PRS.0000000000004684
   PubMed Web of Science ®Google Scholar
• Hay DC, Kemp GD, Dargemont C, Hay RT. Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol. 2001;21(10):3482–3490. doi:10.1128/MCB.21.10.3482-3490.2001
   PubMed Web of Science ®Google Scholar
• Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118. doi:10.1038/s41580-020-00315-9
   PubMed Web of Science ®Google Scholar